| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| bevacizumab amd | 0.69 | 1 | 5725 | 85 | 15 |
| bevacizumab | 0.19 | 0.1 | 1035 | 83 | 11 |
| amd | 0.62 | 0.9 | 6986 | 93 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| bevacizumab amd | 0.39 | 0.2 | 2220 | 23 |
| bevacizumab and ovarian cancer | 0.65 | 0.4 | 8642 | 14 |
| bevacizumab and atezolizumab | 1.76 | 0.4 | 1804 | 71 |
| bevacizumab and temozolomide | 1.71 | 0.4 | 7099 | 59 |
| bevacizumab and egpa | 1.52 | 0.6 | 7763 | 94 |
| bevacizumab and urine protein | 0.33 | 0.7 | 4886 | 17 |
| bevacizumab and proteinuria | 1.57 | 0.4 | 750 | 4 |
| bevacizumab and 5 fu | 1.85 | 0.2 | 8591 | 99 |
| bevacizumab and lactation warnings | 0.48 | 1 | 3612 | 71 |
| bevacizumab and autophagy | 0.97 | 1 | 9985 | 55 |
| bevacizumab and lonsurf | 0.45 | 0.5 | 8905 | 39 |
| bevacizumab and surgery | 0.64 | 0.7 | 2103 | 86 |
| bevacizumab and olaparib | 1.85 | 0.6 | 9825 | 57 |
| bevacizumab and trastuzumab | 0.33 | 0.5 | 5438 | 40 |
| bevacizumab and hypertension | 0.35 | 0.5 | 8260 | 75 |
| bevacizumab for wet amd | 0.45 | 0.6 | 3358 | 60 |
